These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8991043)

  • 41. [Subcutaneous calcium heparinate: a new heparin].
    Desrochers Y
    Union Med Can; 1975 May; 104(5):722-8. PubMed ID: 1136066
    [No Abstract]   [Full Text] [Related]  

  • 42. Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban.
    Tardy-Poncet B; Piot M; Montmartin A; Burdier A; Chalayer E; Tardy B
    Thromb Haemost; 2015 Aug; 114(3):652-4. PubMed ID: 26062524
    [No Abstract]   [Full Text] [Related]  

  • 43. [Biological monitoring of antithrombosis treatments (author's transl)].
    Samama M
    Ann Cardiol Angeiol (Paris); 1981 Dec; 30(7):483-6. PubMed ID: 7332257
    [No Abstract]   [Full Text] [Related]  

  • 44. [What is guaranteed in fibrinolytic therapy of deep venous thrombosis?].
    Seifried E
    Internist (Berl); 1990 Nov; 31(11):689-97. PubMed ID: 2289854
    [No Abstract]   [Full Text] [Related]  

  • 45. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Argatroban for anticoagulation in pediatric patients with heparin-induced thrombocytopenia requiring extracorporeal life support.
    Potter KE; Raj A; Sullivan JE
    J Pediatr Hematol Oncol; 2007 Apr; 29(4):265-8. PubMed ID: 17414571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enoxaparin and fibrinolysis: ExTRACTing prognosis from bleeding complications.
    Sinnaeve P; Van de Werf F
    Eur Heart J; 2010 Sep; 31(17):2077-9. PubMed ID: 20525980
    [No Abstract]   [Full Text] [Related]  

  • 48. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
    Roĭtman EV; Dement'eva II; Meshcheriakov AV
    Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 50. Treating heparin-induced thrombocytopenia. The unconventional way!
    Abdel-Razeq HN; Bajouda AA; Khalil MM; Ashmeg AK
    Saudi Med J; 2004 Sep; 25(9):1258-60. PubMed ID: 15448779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. My doctors were concerned that I had abnormal troponin levels and cardiac symptoms. Prior to a coronary angiogram, I was given an intravenous dose of heparin, and now take a beta-blocker, metoprolol, 12.5 milligrams twice a day. I bleed a lot and bruise when I have a cut or a contusion. Why?
    Heart Advis; 2006 Mar; 9(3):8. PubMed ID: 16642569
    [No Abstract]   [Full Text] [Related]  

  • 52. Substitution of fractionated for unfractionated heparin during high-risk percutaneous coronary intervention: has the problem been solved?
    Eisenberg MJ
    J Am Coll Cardiol; 2007 Jun; 49(23):2247-8. PubMed ID: 17560288
    [No Abstract]   [Full Text] [Related]  

  • 53. [The treatment of pulmonary embolism].
    Efira A
    Rev Med Brux; 1983 May; 4(5):361-6. PubMed ID: 6878941
    [No Abstract]   [Full Text] [Related]  

  • 54. Heparin therapy: current regimens and principles of monitoring.
    Berry BR; Nantel S
    Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progressive, Fatal Thrombosis Associated With Heparin-Induced Thrombocytopenia After Cardiac Surgery Despite "Therapeutic" Anticoagulation With Argatroban: Potential Role for PTT and ACT Confounding.
    Smythe MA; Forsyth LL; Warkentin TE; Smith MD; Sheppard JA; Shannon F
    J Cardiothorac Vasc Anesth; 2015 Oct; 29(5):1319-21. PubMed ID: 25169901
    [No Abstract]   [Full Text] [Related]  

  • 57. Giant biventricular thrombi in a patient with heart failure and heparin-induced thrombocytopenia.
    Rigger J; Ehl NF; Nägele R; Rickli H; Maeder MT
    Int J Cardiol; 2015 Mar; 182():377-8. PubMed ID: 25594928
    [No Abstract]   [Full Text] [Related]  

  • 58. Heparin calcium treated Henoch-Schönlein purpura nephritis in children through inhibiting hyperfibrinolysis.
    Tian M; Liu C
    Ren Fail; 2015 Aug; 37(7):1100-4. PubMed ID: 26133741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pathogenesis and clinical practice of heparin-induced thrombocytopenia and thrombosis].
    Matsuo T
    Rinsho Ketsueki; 2007 Jan; 48(1):9-18. PubMed ID: 17313072
    [No Abstract]   [Full Text] [Related]  

  • 60. [Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].
    Nielsen JD; Heslet L
    Ugeskr Laeger; 2009 Feb; 171(8):610-1. PubMed ID: 19284906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.